Comparing the Efficacy of Different Zinc Formulations in the Treatment of Diarrhea (Zinc)
Primary Purpose
Incidence of Acute Diarrhea, Incidence of Abdominal Pain
Status
Completed
Phase
Not Applicable
Locations
Pakistan
Study Type
Interventional
Intervention
Zinc Sulphate
Zinc Sulphate
Sponsored by
About this trial
This is an interventional treatment trial for Incidence of Acute Diarrhea focused on measuring Diarrhea, Zinc Sulphate, Efficacy
Eligibility Criteria
Inclusion Criteria:
- Children 6 months to 5 years of age
- Presented with passage of 3 or more loose or watery stools
- Caretakers are willing to let their child to participate in the study.
Exclusion Criteria:
- Failure to produce consent.
- Children with severe malnutrition or having chronic illness
Sites / Locations
- Civil Hospital
- National Institute of Child Health
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
B
A
Arm Description
This group has been given Zinc Sulphate in Suspension Form.
This group has been given Tablets of Zinc Sulphate.
Outcomes
Primary Outcome Measures
Comparison of Efficacy of the two different Zinc Sulphate formulations
Secondary Outcome Measures
Comparison of side effects of the two different Zinc Sulphate formulations used
Full Information
NCT ID
NCT00682955
First Posted
May 20, 2008
Last Updated
May 21, 2008
Sponsor
Aga Khan University
Collaborators
Civil Hospital, Hyderabad, Pakistan, National Institute of Child Health, Karachi, Pakistan
1. Study Identification
Unique Protocol Identification Number
NCT00682955
Brief Title
Comparing the Efficacy of Different Zinc Formulations in the Treatment of Diarrhea
Acronym
Zinc
Official Title
Comparing the Efficacy of Different Zinc Formulations in the Treatment of Acute Diarrhea Among Young Children at Hospital Based Setting in Pakistan
Study Type
Interventional
2. Study Status
Record Verification Date
May 2008
Overall Recruitment Status
Completed
Study Start Date
August 2007 (undefined)
Primary Completion Date
April 2008 (Actual)
Study Completion Date
April 2008 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Aga Khan University
Collaborators
Civil Hospital, Hyderabad, Pakistan, National Institute of Child Health, Karachi, Pakistan
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This project is aimed to evaluate the efficacy of two different zinc formulations (dispersible Zinc tablets versus Zinc suspension) for the treatment of acute diarrhea in hospital based settings. Additionally we intend to compare the effectiveness of treatments of different groups on the basis of usage of Zinc in the treatment of diarrhoea, and to monitor additional treatment components such as ORS, antibiotic usage rates.
Detailed Description
This will be an open randomized trial in children designed to measure the impact and efficacy of daily zinc administration. There will be two groups in the study, one group will receive Zinc in the form tablets, other will receive in the form of suspension, both of these groups will also receive recommended treatment of diarrhea as per WHO protocol and these groups will be enrolled from the patients admitting in the Paediatric Unit of Civil Hospital, Hyderabad and NICH, Karachi with the complain of acute diarrhoea.
The intervention study will be undertaken in hospital based settings. A total recruitment of 300(150 each in each group) has been targetted during the study duration. The duration of this study shall be 9 months.
A brief history will be taken regarding the current illness and will be noted down in the specific forms. After the history the patient will be completely examined by the duty doctors, examination will emphasize of the vitals, status of dehydration and anthropometry. Patient will then be randomized in one of the groups and the procedure of using Zinc tablets or suspension will be explained to the mother or caretaker.The patient will be advised treatment according to the general condition and state of the dehydration and general health. All treatments will be noted down in the specific forms to have a record of what have been given to the patient and to keep the record of fluid intake. Stool samples for the detailed report and culture and sensitivity will be collected & sent to have the information regarding the status of stool and any isolated organism.
Follow-ups
The patients will be followed & examined thoroughly every 8 hourly till the time of discharge by a trained RMO.
At each follow up, details of illness characteristics, including the number and character of stools and vomiting, will be obtained.
Information regarding the associated symptoms including fever, abdominal pain distension and dysentery will be obtained. Hydration status, vitals and weight will also be assessed.
RMO will record about the proper dosages of zinc and confirm that weather or not patient is taking his medications during every follow up
RMO will also document the recovery of diarrhea in terms of reduction in frequency and duration of diarrhoea and all the information will be noted in the assigned follow up forms.
Any adverse effect of the associated with the Zinc will also be recorded.
Compliance will be measured by reported intake and by measuring the remaining volume of syrup in the returned bottles and number of tablets used in the blisters.
At the time of discharge a discharge summary form is also filled by RMO
The patients who will be discharged will be followed at home for a total of two weeks of illness.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Incidence of Acute Diarrhea, Incidence of Abdominal Pain
Keywords
Diarrhea, Zinc Sulphate, Efficacy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
300 (Actual)
8. Arms, Groups, and Interventions
Arm Title
B
Arm Type
Active Comparator
Arm Description
This group has been given Zinc Sulphate in Suspension Form.
Arm Title
A
Arm Type
Active Comparator
Arm Description
This group has been given Tablets of Zinc Sulphate.
Intervention Type
Drug
Intervention Name(s)
Zinc Sulphate
Other Intervention Name(s)
Zincol
Intervention Description
20 mg per day, Zinc Sulphate tablet has been given to subjects.
Intervention Type
Drug
Intervention Name(s)
Zinc Sulphate
Other Intervention Name(s)
Zincat
Intervention Description
20 mg per day of Zinc Sulphate in suspension form has been given to subjects.
Primary Outcome Measure Information:
Title
Comparison of Efficacy of the two different Zinc Sulphate formulations
Time Frame
9 months
Secondary Outcome Measure Information:
Title
Comparison of side effects of the two different Zinc Sulphate formulations used
Time Frame
9 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Children 6 months to 5 years of age
Presented with passage of 3 or more loose or watery stools
Caretakers are willing to let their child to participate in the study.
Exclusion Criteria:
Failure to produce consent.
Children with severe malnutrition or having chronic illness
Facility Information:
Facility Name
Civil Hospital
City
Hyderabad
State/Province
Sindh
ZIP/Postal Code
75300
Country
Pakistan
Facility Name
National Institute of Child Health
City
Karachi
State/Province
Sindh
ZIP/Postal Code
75300
Country
Pakistan
12. IPD Sharing Statement
Learn more about this trial
Comparing the Efficacy of Different Zinc Formulations in the Treatment of Diarrhea
We'll reach out to this number within 24 hrs